Public Profile

Photocure

Photocure ASA, a pioneering biopharmaceutical company headquartered in Norway, is at the forefront of developing innovative solutions for bladder cancer treatment. Founded in 1997, Photocure has made significant strides in the industry, particularly with its flagship product, Hexvix, which enhances the detection of bladder cancer during cystoscopy procedures. With a strong presence in Europe and expanding operations in North America, Photocure is dedicated to improving patient outcomes through its unique photodynamic technology. The company has established itself as a leader in the urology sector, recognised for its commitment to advancing bladder cancer care. Photocure's focus on research and development continues to drive its market position, making it a key player in the biopharmaceutical landscape.

DitchCarbon Score

How does Photocure's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

51

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Photocure's score of 51 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.

85%

Let us know if this data was useful to you

Photocure's reported carbon emissions

In 2023, Photocure reported total carbon emissions of approximately 21.6 tonnes CO2e, with emissions distributed across various scopes: 2.16 tonnes CO2e from Scope 1, 57.2 tonnes CO2e from Scope 2, and 1.84 tonnes CO2e from Scope 3. This reflects a slight increase in total emissions compared to 2022, where they recorded about 14.1 tonnes CO2e, with Scope 1 emissions at 1.41 tonnes CO2e, Scope 2 at 57.3 tonnes CO2e, and Scope 3 at 4.89 tonnes CO2e. Photocure has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 emissions to near zero by the middle of this decade (2025). This commitment underscores their proactive approach to addressing climate change and aligns with industry standards for sustainability. The company has disclosed emissions data across all relevant scopes, demonstrating transparency in their environmental impact reporting. Overall, Photocure's emissions strategy reflects a commitment to significant reductions in their carbon footprint, contributing to broader climate goals.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202120222023
Scope 1
1,980
0,000
0,000
Scope 2
32,416
00,000
00,000
Scope 3
2,890
0,000
0,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Photocure's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Photocure is in NO, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Photocure is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers